concept

CIRCADIAN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CIRCADIAN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

90Connections

14Hypotheses

0Analyses

50Outgoing

26Incoming

20Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CIRCADIAN

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Circadian Rhythm in Neurodegeneration

mechanism · 4939 words

→

Pathway Diagram

graph TD
    CIRCADIAN["CIRCADIAN"]
    CIRCADIAN -->|"interacts"| Melatonin["Melatonin"]
    CIRCADIAN ---|"co-discussed"| LIPID_METABOLISM["LIPID METABOLISM"]
    CIRCADIAN ---|"co-discussed"| NEURON["NEURON"]
    CIRCADIAN ---|"co-discussed"| NEURONS["NEURONS"]
    CIRCADIAN ---|"co-discussed"| SLEEP["SLEEP"]
    CIRCADIAN ---|"co-discussed"| STING["STING"]
    Melatonin -->|"activates"| CIRCADIAN
    ANGIOGENESIS["ANGIOGENESIS"] ---|"co-discussed"| CIRCADIAN
    AKT["AKT"] ---|"co-discussed"| CIRCADIAN
    ALZHEIMER["ALZHEIMER"] ---|"co-discussed"| CIRCADIAN
    ALZHEIMER_S["ALZHEIMER'S"] ---|"co-discussed"| CIRCADIAN
    ASTROCYTE["ASTROCYTE"] ---|"co-discussed"| CIRCADIAN

Outgoing (64)

Target	Relation	Type	Str
Melatonin	interacts_with	entity	0.70
ENDOTHELIAL	co_discussed	entity	0.50
CYTOKINE	co_discussed	entity	0.50
MACROPHAGE	co_discussed	entity	0.50
ERK	co_discussed	entity	0.50
OCLN	co_discussed	entity	0.50
TNF	co_discussed	entity	0.50
DEPRESSION	co_discussed	entity	0.50
EPIGENETIC	co_discussed	entity	0.50
DOPAMINERGIC	co_discussed	entity	0.50
GABA	co_discussed	entity	0.50
GABAergic	co_discussed	entity	0.50
NEURODEGENERATION	co_discussed	entity	0.50
HUNTINGTON	co_discussed	entity	0.50
PARKINSON	co_discussed	entity	0.50
PARKINSON'S	co_discussed	entity	0.50
NEUROINFLAMMATION	co_discussed	entity	0.50
MITOCHONDRIAL DYSFUNCTION	co_discussed	entity	0.50
PERICYTE	co_discussed	entity	0.50
PERICYTES	co_discussed	entity	0.50
STROKE	co_discussed	entity	0.50
SEROTONERGIC	co_discussed	entity	0.50
LC3	co_discussed	entity	0.50
SUBSTANTIA NIGRA	co_discussed	entity	0.50
PHAGOCYTOSIS	co_discussed	entity	0.50
HISTONE	co_discussed	entity	0.50
CR1	co_discussed	entity	0.50
DEMENTIA	co_discussed	entity	0.50
FRONTOTEMPORAL	co_discussed	entity	0.50
MITOCHONDRIA	co_discussed	entity	0.50
MTOR	co_discussed	entity	0.50
T CELLS	co_discussed	entity	0.50
COMPLEMENT	co_discussed	entity	0.50
HIPPOCAMPUS	co_discussed	entity	0.50
MICROGLIA	co_discussed	entity	0.50
GLYMPHATIC	co_discussed	entity	0.50
TAU	co_discussed	entity	0.50
CORTEX	co_discussed	entity	0.50
PREFRONTAL	co_discussed	entity	0.50
SCHIZOPHRENIA	co_discussed	entity	0.50
SENESCENCE	co_discussed	entity	0.50
FTD	co_discussed	entity	0.50
TDP-43	co_discussed	entity	0.50
FERROPTOSIS	co_discussed	entity	0.50
GLUTAMATE	co_discussed	entity	0.50
LIPID METABOLISM	co_discussed	entity	0.50
NEURON	co_discussed	entity	0.50
NEURONS	co_discussed	entity	0.50
SLEEP	co_discussed	entity	0.50
STING	co_discussed	entity	0.50

Incoming (26)

Source	Relation	Type	Str
Melatonin	activates	entity	0.70
Melatonin	inhibits	entity	0.70
Melatonin	regulates	entity	0.70
Melatonin	interacts_with	entity	0.70
ALZHEIMER	co_discussed	entity	0.50
ALZHEIMER'S	co_discussed	entity	0.50
ASTROCYTE	co_discussed	entity	0.50
APP	co_discussed	entity	0.50
CALCIUM SIGNALING	co_discussed	entity	0.50
CHOLINERGIC	co_discussed	entity	0.50
ASTROCYTES	co_discussed	entity	0.50
ALS	co_discussed	entity	0.50
CDK5	co_discussed	entity	0.50
BLOOD-BRAIN BARRIER	co_discussed	entity	0.50
AMPK	co_discussed	entity	0.50
ASTROCYTES	contributes_to	entity	0.50
AMYGDALA	co_discussed	entity	0.50
BBB	co_discussed	entity	0.50
ANGIOGENESIS	co_discussed	entity	0.50
AKT	co_discussed	entity	0.50
AQP4	co_discussed	entity	0.50
APOPTOSIS	co_discussed	entity	0.50
BDNF	co_discussed	entity	0.50
AXON	co_discussed	entity	0.50
APOE	co_discussed	entity	0.50
AUTOPHAGY	co_discussed	entity	0.50

Targeting Hypotheses (14)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Circadian Glymphatic Entrainment via Targeted Orexin Recepto	0.841	neurodegeneration	Perivascular spaces and glymphatic clear
Circadian Clock-Autophagy Synchronization	0.763	neurodegeneration	Sleep disruption as cause and consequenc
Circadian-Synchronized Proteostasis Enhancement	0.744	neurodegeneration	Digital biomarkers and AI-driven early d
Circadian Rhythm Entrainment of Reactive Astrocytes	0.722	neurodegeneration	Astrocyte reactivity subtypes in neurode
Circadian-Synchronized LRP1 Pathway Activation	0.714	neurodegeneration	Blood-brain barrier transport mechanisms

Circadian Glymphatic Rescue Therapy (Melatonin-focused)	0.712	neurodegeneration	Sleep disruption as cause and consequenc
Circadian-Metabolic Microglial Reprogramming	0.662	-	Neuroinflammation and microglial priming
Circadian-Gated Ketone Window Hypothesis	0.606	metabolic neuroscience	What determines the optimal timing and d
HIF1A stabilization lowers the activation threshold of circa	0.566	neuroinflammation	Do microglia actually switch between gly
Circadian-Gated Maresin Biosynthesis Amplification	0.557	neurodegeneration	Neuroinflammation resolution mechanisms
Temporal Decoupling via Circadian Clock Reset	0.543	neurodegeneration	Microglia-astrocyte crosstalk amplificat
Circadian Epigenetic Ketone Synchronization Protocol	0.543	metabolic neuroscience	What determines the optimal timing and d
Circadian Clock Epigenetic Desynchronization Window	0.524	neurodegeneration	What is the optimal therapeutic window d
Circadian Rhythm Amplification to Restore Network Oscillatio	0.360	connectomics	Human connectome alterations in Alzheime

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Circadian gene expression effects of SD vs ketamine	exploratory	depression	0.950	0.00	C57BL/6J mice	proposed	N/A
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co	clinical	Alzheimer's Disease	0.900	0.50	aortic endothelial cells	proposed	$6,550,000
CLOCK/BMAL1 regulation of ICC autophagy in GERD model	exploratory	gastroesophageal reflux diseas	0.900	0.00	primary esophageal interstitia	proposed	N/A
Ketogenic diet efficacy in diet-induced obese mice	validation	obesity, metabolic disease	0.900	0.00	C57BL/6J diet-induced obese mi	proposed	N/A
s:** - Test tau spreading in AQP4 knockout vs wild-type mice with PSP/	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$260,000
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Trial	clinical	Neurodegeneration	0.400	0.50	human	proposed	$3,900,000
DLB Cognitive Fluctuation Mechanism Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
NPH Glymphatic System Interaction Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Sleep and Circadian Dysfunction as Driver of Neurodegeneration	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Sleep Disruption and Alzheimer's Disease — mechanism and intervention	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Sleep and Respiratory Network Interaction in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$5,460,000
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Proposed experiment from debate on Epigenetic clocks and biological ag	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
Experiment Index	validation	Neurodegeneration	0.400	0.50	human	proposed	$2,280,000
Macroautophagy Dysfunction in PD - Experiment Design	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
N-of-1 Clinical Trial Design for CBS/PSP	clinical	ALS	0.400	0.50	human	proposed	$5,460,000
Normal Aging to Alzheimer's Disease Transition Trigger — Identifying t	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,280,000
Autophagy Enhancement Drug Screening for Neurodegeneration	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Allosteric properties of mammalian ALOX15 orthologs. [PMID:41654134]	Yang J, Borchert A, Kuhn H	J Biol Chem	2026	1
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury. [PMID:40269168]	Ruan W, Li T, Bang IH, Lee J, Deng W, Ma	Nature	2025	1
Obstructive sleep apnea syndrome, orexin, and sleep-wake cycle: The link with th [PMID:39864923]	Fernandes M, Liguori C	Handb Clin Neurol	2025	1
From geroscience to precision geromedicine: Understanding and managing aging. [PMID:40250404]	Kroemer G, Maier AB, Cuervo AM, Gladyshe	Cell	2025	1
Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake [PMID:40439868]	Zheng Z, Xue F, Wang H, Gu Q, Hu R, Li X	Pharmacol Rep	2025	1
Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases. [PMID:39728504]	Hussain Y, Dar MI, Pan X	Metabolites	2024	1
Circadian rhythm regulates the function of immune cells and participates in the [PMID:38678017]	Zeng Y, Guo Z, Wu M, Chen F, Chen L	Cell Death Discov	2024	1
SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxid [PMID:38516826]	He G, Zhang Y, Feng Y, Chen T, Liu M, Ze	J Cell Mol Med	2024	1
BMAL1 involved in autophagy and injury of thoracic aortic endothelial cells of r [PMID:37086572]	Chunli Yang, Ziwei Deng, Qihang Zeng, Xi	Biochemical and biophysical re	2023	1
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044]	Calvier L, Herz J, Hansmann G	JACC Basic Transl Sci	2022	1
Genetic determinants of daytime napping and effects on cardiometabolic health. [PMID:33568662]	Dashti HS, Daghlas I, Lane JM, Huang Y,	Nat Commun	2021	1
Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress di [PMID:33285346]	Cénat JM, Blais-Rochette C, Kokou-Kpolou	Psychiatry Res	2021	1
Improved T-cell Receptor Diversity Estimates Associate with Survival and Respons [PMID:33177107]	Bortone DS, Woodcock MG, Parker JS, Vinc	Cancer Immunol Res	2021	1
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. [PMID:34052813]	Sun Y, Tisdale RK, Kilduff TS	Front Neurol Neurosci	2021	1
Circadian Clock Regulation on Lipid Metabolism and Metabolic Diseases. [PMID:32705594]	Pan X, Mota S, Zhang B	Adv Exp Med Biol	2020	1
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Seque [PMID:32822576]	Maynard A, McCoach CE, Rotow JK, Harris	Cell	2020	1
The Ca(2+) Sensor SCaBP3/CBL7 Modulates Plasma Membrane H(+)-ATPase Activity and [PMID:30962395]	Yang Y, Wu Y, Ma L, Yang Z, Dong Q, Li Q	Plant Cell	2019	1
ALOX12 is required for p53-mediated tumour suppression through a distinct ferrop [PMID:30962574]	Chu B, Kon N, Chen D, Li T, Liu T, Jiang	Nat Cell Biol	2019	1
Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. [PMID:30472260]	Singh NK, Rao GN	Prog Lipid Res	2019	1
An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-rep [PMID:29227475]	Zhang XJ, Cheng X, Yan ZZ, Fang J, Wang	Nat Med	2018	1

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CIRCADIAN in their description or question text

Circadian Glymphatic Rescue Therapy (Melatonin-focused)

Score: 0.712 · neurodegeneration · 2026-04-02

## Mechanistic Overview Circadian Glymphatic Rescue Therapy (Melatonin-focused) starts from the claim that modulating MT

Circadian-Metabolic Microglial Reprogramming

Score: 0.662 · unknown disease · 2026-04-04

## Mechanistic Overview Circadian-Metabolic Microglial Reprogramming starts from the claim that modulating CLOCK, BMAL1,

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 · metabolic neuroscience · 2026-04-16

**Molecular Mechanism and Rationale** The circadian-gated ketone window hypothesis centers on the orchestrated regulati

HIF1A stabilization lowers the activation threshold of circadian-disrupted micro

Score: 0.566 · neuroinflammation · 2026-04-21

## **Molecular Mechanism and Rationale** The molecular mechanism underlying this hypothesis centers on the stabilizatio

Circadian-Gated Maresin Biosynthesis Amplification

Score: 0.557 · neurodegeneration · 2026-04-02

## Mechanistic Overview Circadian-Gated Maresin Biosynthesis Amplification starts from the claim that modulating ALOX12

Temporal Decoupling via Circadian Clock Reset

Score: 0.543 · neurodegeneration · 2026-04-02

## Mechanistic Overview Temporal Decoupling via Circadian Clock Reset starts from the claim that modulating CLOCK within

Circadian Epigenetic Ketone Synchronization Protocol

Score: 0.543 · metabolic neuroscience · 2026-04-20

## Mechanistic Overview Circadian Epigenetic Ketone Synchronization Protocol starts from the claim that modulating CLOCK

Circadian Clock Epigenetic Desynchronization Window

Score: 0.524 · neurodegeneration · 2026-04-21

## Mechanistic Overview Circadian Clock Epigenetic Desynchronization Window starts from the claim that modulating BMAL1/

Circadian Rhythm Amplification to Restore Network Oscillation Synchronization

Score: 0.360 · connectomics · 2026-04-25

Circadian Rhythm Amplification to Restore Network Oscillation Synchronization